Abstract
Introduction
Preeclampsia is a multisystem pathological condition that occurs in the second half of pregnancy (after the 20th week) characterized by hypertension in combination with proteinuria, often with edema and multiple organ dysfunction (Williams et al, 2011 , Sidorova, 2016 . The frequency of PE is 8-20% among all pregnant women (Suhih, Murashko, 2010) . During the last decade, preeclampsia is one of the main factors of perinatal morbidity in the world and stably ranks 3rd-4th in the structure of the causes of maternal morbidity and mortality (Ajlamazyan, Mozgovaya, 2010, Sidorova, 2016) . Analysis of modern literature indicates that PE is a multifactorial disease. Genetic component of PE development can account for up to 50% of all risk factors (Baranov, 2009; Reshetnikov et al., 2017 ). An important role in the etiology and pathogenesis of preeclampsia belongs to the candidate genes for folate metabolism (Vorozhishcheva, 2014; Zhou et al., 2016) . Mutations in the genes of folate metabolism, which lead to a decrease in the activity of methyltetrahydrofolate reductase enzymes and methionine synthase reductase, lead to an excessive accumulation of homocysteine in the blood and, as a result, disruption of methylation processes in cells (Vorozhishcheva, 2014) . Deficiency of folic acid causes the formation of hypertension in pregnant women, the development of total angiopathy, microthrombosis, increased insulin resistance. It should be noted that the role of candidate genes for folate metabolism in the formation of PE has been actively studied, but these studies often give conflicting results in different populations of the world (Obolenska et al. 
Materials and Methods

Group characteristics
According to the goals and objectives of the study, 501 women were examined: 322 pregnant women diagnosed with preeclampsia and 179 women with normal pregnancy (control group). All clinical studies were carried out according to the protocols of the ethical committee of the Russian Federation, with the informed consent of the patients. The present study includes persons of Russian nationality not being of kin to each other, born in the Central Black Earth region of Russia. Clinical and laboratory examination of women of the main and control groups was performed at the time of delivery in the Perinatal Center of St. Joasaph Belgorod Regional Clinical Hospital. The main group included pregnant women diagnosed with preeclampsia. The diagnosis of preeclampsia was based on generalized edema, arterial hypertension and proteinuria (Sidorova, Copyright © 2018 Helix ISSN 2319 -5592 (Online) 2016). The average age of women with PE was 27.19±6.4 years (ranging from 18 to 44 years). The control group included pregnant women without preeclampsia aged 19 to 41 years (mean age of women was 26.71±6.36 years) (p>0.05). Thus, the control group of pregnant women did not differ from the main group by sex, place of birth, age and nationality. Exclusion criteria for the formation of the sample were: the presence of uterine pathology (uterine fibroids, internal genital abnormalities) among patients, pathology of pregnancy (abnormal attachment and location of the placenta, rhesusconflict), fetal pathology (congenital malformations), and multiple pregnancy. Blood pressure (BP, mm Hg) in pregnant women was measured three times on both hands in a sitting position at intervals of one minute. The mean of the last two measurements were taken for the final BP. Data on the level of systolic and diastolic blood pressure in women before pregnancy were copied from their case records. All pregnant women underwent the necessary laboratory examination, including: complete blood count, coagulogram, blood chemistry, common urine analysis (protein, specific gravity, epithelium, leukocytes, cylinders), Nechiporenko urine analysis, and Zimnitskii urine analysis (leukocytes, erythrocytes).
Molecular and Genetic Methods
On the basis of the Human Molecular Genetics research laboratory of Belgorod State National Research University, all pregnant women with preeclampsia and the control group were typed their polymorphic variants of folate cycle genes: methylenetetrahydrofolate reductase (MТHFR +677С>Т (rs1801133), MТHFR +1298 A>С (rs1801131), methionine synthase reductase (MТRR +66 A>G (rs1801394)), and methionine synthase (MТR +2756 A>G (rs1805087)). The material for the study was venous blood obtained in the volume of 8-9 ml from the ulnar vein of the pregnant women. All polymorphic variants of folate cycle enzymes were analyzed with the use of real-time DNA polymerase chain reaction (PCR) (Real-time-PCR).
Statistical Methods
The formation of database and the statistical calculations were carried out using the "STATISTICA 6.0" program. Genetic and phenotypic frequencies were calculated by standard methods. The conformity of the observed distribution of genotypes to the expected one, based on the Hardy-Weinberg equilibrium, was performed using the χ 2 criterion. In order to minimize the errors of the first kind (false positive results), the Bonferroni correction was used for multiple comparisons. Investigation of the relations of polymorphic variants with pathogenetically significant quantitative characteristics of PE (blood pressure level, fibrinogen level, prothrombin index, etc.) was carried out using nonparametric statistics (Rebrova, 2006) . 
Results
As
Conclusion
The data obtained as a result of the research broaden the understanding of the mechanisms of preeclampsia development, and also allows predicting the nature of the clinical course of the disease, which will ensure optimization of the treatment and diagnostic process for each patient. The polymorphisms MТR +2756 A>G, MТHFR +1298 A>С, MТHFR +677С>Т, MТRR +66 A>G can be used to predict blood pressure levels, proteinuria levels, and protein content in pregnant women with preeclampsia.
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